HDAC2‐dependent miRNA signature in acute myeloid leukemia

Acute myeloid leukemia (AML) arises from a complex sequence of biological and finely orchestrated events that are still poorly understood. Increasingly, epigenetic studies are providing exciting findings that may be exploited in promising and personalized cutting‐edge therapies. A more appropriate a...

Full description

Saved in:
Bibliographic Details
Published in:FEBS letters 2019-09, Vol.593 (18), p.2574-2584
Main Authors: Conte, Mariarosaria, Dell'Aversana, Carmela, Sgueglia, Giulia, Carissimo, Annamaria, Altucci, Lucia
Format: Article
Language:English
Subjects:
epigenetics
HDAC2
immunoregulation
leukemia
miRNA
SAHA
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acute myeloid leukemia (AML) arises from a complex sequence of biological and finely orchestrated events that are still poorly understood. Increasingly, epigenetic studies are providing exciting findings that may be exploited in promising and personalized cutting‐edge therapies. A more appropriate and broader screening of possible players in cancer could identify a master molecular mechanism in AML. Here, we build on our previously published study by evaluating a histone deacetylase (HDAC)2‐mediated miRNA regulatory network in U937 leukemic cells. Following a comparative miRNA profiling analysis in genetically and enzymatically HDAC2‐downregulated AML cells, we identified miR‐96‐5p and miR‐92a‐3p as potential regulators in AML etiopathology by targeting defined genes. Our findings support the potentially beneficial role of alternative physiopathological interventions.
ISSN:0014-5793
1873-3468
DOI:10.1002/1873-3468.13521